Skip to main content

Table 1 Geographical distribution of PE activities (note that each PE initiative reported in an article included in this review may have been conducted in more than one location; hence the number of locations is higher than the number of reported initiatives)

From: Practices of patient engagement in drug development: a systematic scoping review

Number of publications

Country

47

USA

18

The UK

13

Germany

7

Australia, Canada, and Poland

6

Italy

5

Czechia and South Korea

4

Bulgaria Mexico, Norway and Spain

3

Brazil, France, Ukraine and Taiwan

2

Russia, China, Japan, Thailand, Slovakia, Sweden, Philippines, Ireland, Israel, India, Greece, Dominican Republic, Croatia, Colombia, and Chile

1

Estonia, South Africa, Romania, Puerto Rico, Malaysia, Hungary, Finland, Denmark, Cyprus, Costa Rica, Bosnia and Herzegovina, Japan, Austria, and Argentina

*

Europe = 6; North America = 1; South America = 1